Additionally, there is a growing trend among pharmaceutical and biotechnology companies to outsource their fill finish manufacturing processes to contract manufacturers. This strategy allows companies to focus on their core competencies while benefiting from specialized expertise and economies of scale, further contributing to the market's growth.